Advertisement

Topics

Comparing Acura Pharmaceuticals

08:06 EDT 30 Jul 2017 | Topix

Acura Pharmaceuticals and Flamel Technologies are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitabiliy and earnings. Acura Pharmaceuticals has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500.

Original Article: Comparing Acura Pharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "Comparing Acura Pharmaceuticals"

Quick Search
Advertisement